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Abstract
Background: Several data mining methods require data that are discrete, and other methods often perform better
with discrete data. We introduce an efficient Bayesian discretization (EBD) method for optimal discretization of
variables that runs efficiently on high-dimensional biomedical datasets. The EBD method consists of two
components, namely, a Bayesian score to evaluate discretizations and a dynamic programming search procedure
to efficiently search the space of possible discretizations. We compared the performance of EBD to Fayyad and
Irani’s (FI) discretization method, which is commonly used for discretization.
Results: On 24 biomedical datasets obtained from high-throughput transcriptomic and proteomic studies, the
classification performances of the C4.5 classifier and the naïve Bayes classifier were statistically significantly better
when the predictor variables were discretized using EBD over FI. EBD was statistically significantly more stable to
the variability of the datasets than FI. However, EBD was less robust, though not statistically significantly so, than FI
and produced slightly more complex discretizations than FI.
Conclusions: On a range of biomedical datasets, a Bayesian discretization method (EBD) yielded better
classification performance and stability but was less robust than the widely used FI discretization method. The EBD
discretization method is easy to implement, permits the incorporation of prior knowledge and belief, and is
sufficiently fast for application to high-dimensional data.
Background
With the advent of high-throughput techniques, such as
DNA microarrays and mass spectrometry, transcrip-
tomic and proteomic studies are generating an abun-
dance of high-dimensional biomedical data. The analysis
of such data presents significant analytical and computa-
tional challenges, and increasingly data mining techni-
ques are being applied to these data with promising
results [1-4]. A typical task in such analysis, for example,
entails the learning of a mathematical model from gene
expression or protein expression data that predicts well
a phenotype, such as disease or health. In data mining,
such a task is called classification and the model that is
learned is termed a classifier. The variable that is pre-
dicted is called the target variable (or simply the target),
which in statistical terminology is referred to as the
response or the dependent variable. The features used
in the prediction are called the predictor variables (or
simply the predictors), which are referred to as the cov-
ariates or the independent variables in statistical
terminology.
A large number of data mining methods have been
developed for classification; several of these methods are
unable to use continuous data and require discrete data
[1-3]. For example, most rule learning methods that
induce sets of IF-THEN rules and several of the popular
methods that learn Bayesian networks require data that
are discrete. Some methods that accept continuous data,
as for example methods that learn classification trees,
discretize the data internally during learning. Other
methods, such as the naïve Bayes classifier, that accept
both continuous and discrete data, may perform better
with discrete data [3,4]. A variety of discretization meth-
ods have been developed for converting continuous data
to discrete data [5-11], and one that is commonly used
is Fayyad and Irani’s (FI) discretization method [9].
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zation method and evaluate its performance on several
high-dimensional transcriptomic and proteomic datasets,
and we compare its performance to that of the FI dis-
cretization method. The remainder of this paper is
structured as follows. The next section provides some
background on discretization and briefly reviews the FI
discretization method. The results section describes the
efficient Bayesian discretization (EBD) method and gives
the results of an evaluation of EBD and FI on biomedi-
cal transcriptomic and proteomic datasets. The final sec-
tion discusses the results and draws conclusions.
Discretization
Numerical variables may be continuous or discrete.A
continuous variable is one which takes an infinite num-
ber of possible values within a range or an interval. A
discrete variable is one which takes a countable number
of distinct values. A discrete variable may take few
values or a large number of values. Discretization is a
process that transforms a variable, either discrete or
continuous, such that it takes a fewer number of values
by creating a set of contiguous intervals (or equivalently
a set of cut points) that spans the range of the variable’s
values. The set of intervals or the set of cut points
produced by a discretization method is called a
discretization.
Discretization has several advantages. It broadens the
range of classification algorithms that can be applied to
datasets since some algorithms cannot handle continu-
ous attributes. In addition to being a necessary pre-pro-
cessing step for classification methods that require
discrete data, discretization has been shown to increase
the accuracy of some classifiers, increase the speed of
classification methods especially on high-dimensional
data, and provide better human interpretability of mod-
els such as IF-THEN rule sets [8,10,11]. The impact of
discretization on the performance of classifiers is not
only due to the conversion of continuous values to dis-
crete ones, but also due to filtering of the predictor vari-
ables [4]. Variables that are discretized to a single
interval are effectively filtered out and discarded by clas-
sification methods since they are not predictive of the
target variable. Due to redundancy and noise in the pre-
dictor variables in high-dimensional transcriptomic and
proteomic data, such filtering of variables has the poten-
tial to improve classification performance. Even classifi-
cation methods like Support Vector Machines and
Random Forests that handle continuous variables
directly and are robust to high dimensionality of the
data may benefit from discretization [4]. The main dis-
advantage of discretization is the loss of information
entailed in the process that has the potential to reduce
performance of classifiers if the information loss is
relevant for classification. However, this theoretical con-
cern may or may not be a practical one, depending on
the particular machine-learning situation.
Discretization methods can be classified as unsuper-
vised or supervised. Unsupervised methods do not use
any information about the target variable in the discreti-
zation process while supervised methods do. Examples
of unsupervised methods include the Equal-Width
method, which partitions the range of variable’sv a l u e s
into a user-specified number of intervals and the Equal-
Frequency method, which partitions the range of vari-
able’s values into a user-specified fraction of instances
per interval. Compared to unsupervised methods, super-
vised methods tend to be more sophisticated and typi-
cally yield classifiers that have superior performance
[8,10,11]. Most supervised discretization methods con-
sist of a score to measure the goodness of a set of inter-
vals (where goodness is a measure of how well the
discretized predictor variable predicts the target vari-
able), and a search method to locate a good-scoring set
of intervals in the space of possible discretizations. The
commonly used FI method is an example of a super-
vised method.
A second way to categorize discretization methods is
as univariate versus multivariate methods. Univariate
methods discretize a continuous-valued variable inde-
pendently of all other predictor variables in the data,
while multivariate methods take into consideration the
possible interactions of the variable being discretized
with the other predictor variables. Multivariate methods
are rarely used in practice since they are computation-
ally more expensive than univariate methods and have
been developed for specialized applications [12,13]. The
FI discretization method is a typical example of a uni-
variate method.
We now introduce terminology that will be useful for
describing discretization. Let D be a dataset of n
instances consisting of the list ((X1, Z1), (X2, Z2), ..., (Xk,
Zk), ..., (Xn, Zn)) that is sorted in ascending order of Xk,
where Xk is a real value of the predictor variable X and
Zk is the associated integer value of the target variable
Z. For example, suppose that the predictor variable
represents the expression level of a gene that takes real
values in the range 0 to 5.0 and the target variable
represents the phenotype that takes the values: healthy
or diseased (Z =0o rZ = 1, respectively). Then, an
example dataset D is ((1.2, 0), (1.4, 0), (1.6, 0), (3.7, 1),
(3.9, 1), (4.1, 1)). Let Sa, b be a list of the first elements
of D,s t a r t i n ga tt h ea
th pair in D a n de n d i n ga tt h eb
th
pair. Thus, for the above example, S4, 6 = (3.7, 3.9, 4.1).
For brevity, we denote by S the list S1, n. Let Tb b eas e t
that represents a discretization of S1, b. For the above
example of D, a possible 2-interval discretization is T6 =
{S1, 3, S4, 6} = {(1.2, 1.4, 1.6), (3.7, 3.9, 4.1)}. Equivalently,
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1.6 and 3.7, and typically the mid-point is chosen, which
is 2.65 in this example. Thus, all values below 2.65 are
considered as a single discrete value and all values equal
or greater than 2.65 are considered another discrete
value. For brevity, we denote by T a discretization Tn of
S.
Fayyad and Irani’s (FI) Discretization Method
Fayyad and Irani’s discretization method is a univariate
supervised method that is widely used and has been
cited over 2000 times according to Google Scholar
1.
The FI method consists of i) a score that is the entropy
of the target variable induced by the discretization of
the predictor variable, and ii) a greedy search method
that recursively discretizes each partition at a cutpoint
that minimizes the joint entropy of the two resulting
subintervals until a stopping criterion based on the
minimum description length (MDL) is met.
For a list Sa, b derived from a predictor variable X and
at a r g e tv a r i a b l eZ that takes J values, the entropy Ent
(Sa, b) is defined as:
Ent(Sa,b)=
J  
j=1
P(Z = zj)log2P(Z = zj)), (1)
where, P(Z = zj) is the proportion of instances in Sa, b
where the target takes the value zj.T h ee n t r o p yo fZ
can be interpreted as a measure of its uncertainty or
disorder. Let a cutpoint C split the list Sa, b into the lists
Sa, c and Sc +1 ,b to create a 2-interval discretization {Sa,
c, Sc +1 ,b}. The entropy Ent(C; Sa, b) induced by C is
given by:
Ent(C;Sa,b)=
   Sa,c
   
   Sa,b
   Ent(Sa,c)+
   Sc+1,b
   
   Sa,b
    Ent(Sc+1,b), (2)
where, |Sa, b| is the number of instances in Sa, b,| Sa, c|
is the number of instances in Sa, c,a n d| Sc +1 ,b|i st h e
number of instances in Sc +1 ,b. The FI method selects
the cut point C from all possible cut points that mini-
mizes Ent(C; Sa, b) and then recursively selects a cut
point in each of the newly created intervals in a similar
fashion. As partitioning always decreases the entropy of
the resulting discretization, the process of introducing
cut points is terminated by a MDL-based stopping cri-
terion. Intuitively, minimizing the entropy results in
intervals where each interval has a preponderance of
one value for the target.
Overall, the FI method is very efficient and runs in O
(nl o gn ) time, where n is the number of instances in
the dataset. However, since it uses a greedy search
method, it does not examine all possible discretizations
and hence is not guaranteed to discover the optimal
discretization, that is, the discretization with the mini-
mum entropy.
Minimum Optimal Description Length (MODL)
Discretization Method
To our knowledge, the closest prior work to the EBD
algorithm, which is introduced in this paper, is the
M O D La l g o r i t h mt h a tw a sd e v e l o p e db yB o u l l e[ 5 ] .
MODL is a univariate, supervised, discretization algo-
rithm. Both MODL and EBD use dynamic programming
to search over discretization models that are scored
using a Bayesian measure. EBD differs from MODL in
two important ways. First, MODL assumes uniform
prior probabilities over the discretization, whereas EBD
allows an informative specification of both structure and
parameter priors, as discussed in the next section. Thus,
although EBD can be used with uniform prior probabil-
ities as a special case, it is not required to do so. If we
have background knowledge or beliefs that may influ-
ence the discretization process, EBD provides a way to
incorporate them into the discretization process.
Second, the MODL optimal discretization algorithm
has a run time that is O(n
3), whereas the EBD optimal
discretization algorithm has a run time of O(n
2), where
n is the number of instances in the dataset. In essence,
EBD uses a more efficient form of dynamic program-
ming, than does MODL. Their difference in computa-
tional time complexity can have significant practical
consequences in terms of which datasets are feasible to
use. A dataset with, for example, 10,000 instances might
be practical to use in performing discretization using
EBD, but not using MODL.
While heuristic versions of MODL have been
described [5], which give up optimality guarantees in
order to improve computational efficiency, and heuristic
versions of EBD could be developed that further
decrease its time complexity as well, the focus of the
current paper is on optimal discretization.
In the next section, we introduce the EBD algorithm
a n dt h e nd e s c r i b ea ne v a l u a t i o no fi to nas e to fb i o i n -
formatics datasets.
Results
An Efficient Bayesian Discretization Method
We now introduce a new supervised univariate discre-
tization method called efficient Bayesian discretization
(EBD). EBD consists of i) a Bayesian score to evaluate
discretizations, and ii) a dynamic programming search
method to locate the optimal discretization in the
space of possible discretizations. The dynamic pro-
gramming method examines all possible discretizations
and hence is guaranteed to discover the optimal dis-
cretization, that is, the discretization with the highest
Bayesian score.
Lustgarten et al. BMC Bioinformatics 2011, 12:309
http://www.biomedcentral.com/1471-2105/12/309
Page 3 of 15Bayesian Score
We first describe a discretization model and define its
parameters. As before, let X and Z denote the predictor
and target variables, respectively, let D be a dataset of
n instances consisting of the list ((X1, Z1), (X2, Z2), ...,
(Xk, Zk), ..., (Xn, Zn)), as described above, and let S
denote a list of the first elements of D. A discretization
model M is defined as:
M ≡{ W,T, },
where, W is the number of intervals in the discretiza-
tion, T is a discretization of S,a n dΘ is defined as fol-
lows. For a specified interval i, the distribution of the
target variable P(Z | W = i) is modeled as a multinomial
distribution with the parameters {θi 1,θi2,...,θij,...,θiJ}
where j indexes the distinct values of Z. Considering all
the intervals, Θ ={ θij} over 1 ≤ i ≤ I and 1 ≤ j ≤ J and Θ
specifies all the multinomial distributions for all the
intervals in M.G i v e nd a t aD, EBD computes a Bayesian
score for all possible discretizations of S and selects the
one with the highest score.
We now derive the Bayesian score used by EBD to
evaluate a discretization model M. The posterior prob-
ability P(M | D)o fM is given by Bayes rule as follows:
P(M|D)=
P(M) · P(D|M)
P(D)
, (3)
where P(M) is the prior probability of M, P(D | M)i s
the marginal likelihood of the data D given M, and P(D)
is the probability of the data. Since P(D)i st h es a m ef o r
all discretizations, the Bayesian score evaluates only the
numerator on the right hand side of Equation 3 as fol-
lows:
Score(M)=P(M) · P(D|M). (4)
The marginal likelihood P(D | M)i nE q u a t i o n4i s
derived using the following equation:
P(D|M)=
 
 
P(D|M, )P( |M)d , (5)
where Θ are the parameters of the multinomial dis-
tributions as defined above. Equation 5 has a closed-
form solution under the following assumptions: (1) the
values of the target variable were generated according
to i.i.d. sampling from P(Z | W = i), which is modeled
with a multinomial distribution, (2) the distribution P
(Z | W = i) is modeled as being independent of the
distribution P(Z | W = h) for all values of i and h such
that i ≠ h, (3) for all values i, prior belief about the
distribution P(Z | W = i) is modeled with a Dirichlet
distribution with hyperparameters aij,a n d( 4 )t h e r ea r e
no missing data. The closed-form solution to the mar-
ginal likelihood is given by the following expression
[14,15]:
P(D|M)=
I  
i=1
⎡
⎣  (αi)
 (αi + ni)
J  
j=1
 (αij + nij)
 (αij)
⎤
⎦, (6)
where Γ(·) is the gamma function, ni is the number of
instances in the interval i, nij is the number of instances
in the interval Wi that have target-value j, aij are the
hyperparameters in a Dirichlet distribution which define
the prior probability over the θij parameters, and
αi =
J  
j=1
αij. The hyperparameters can be viewed as
prior counts, as for example from a previous (or a
hypothetical) dataset of instances in the interval i that
belong to the value j. For the experiments described in
this paper, we set all the aij to 1, which can be shown
to imply that ap r i o r iwe assume all possible distribu-
tions of P(Z | W = i) to be equally likely, for each inter-
val i.
2 If all aij =1 ,t h e na l lai = J. With these values for
the hyperparameters, and using the fact that Γ(n)=( n-
1)!, Equation 6 becomes the following:
P(D|M)=
I  
i=1
(J − 1)!
(J − 1+ni)!
J  
j=1
nij! (7)
The term P(M) in Equation 4 specifies the prior
probability on the number of intervals and the loca-
tion of the cut points in the discretization model M;
we call these the structure priors. The structure priors
may be chosen to penalize complex discretization
models with many intervals to prevent overfitting. In
addition to the structure priors, the marginal likeli-
hood P(D | M) includes a specification of the prior
probabilities on the multinomial distribution of the
target variable in each interval; we call these the para-
meter priors. In Equation 6, the alphas specify the
parameter priors.
The prior probability P(M) is modeled as follows. Let
Xk denote a real value of the predictor variable, as
described above, and Zk denote the associated integer
value of the target variable. Let Prior(k)b et h ep r i o r
probability of there being at least one cut point between
Xk and Xk +1 . In the Methods section, we describe the
use of a Poisson distribution with mean l to implement
Prior(k), where l is a structure prior parameter. Con-
sider the prior probability for an interval i that repre-
sents the sequence Sai,bi in a discretization model M.I n
general, we assume that the prior probability for interval i
is independent of the prior probabilities for the other
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of the Prior function is defined as follows:
Prior(bi)
⎛
⎝
bi−1  
k=ai
(1 − Prior(k))
⎞
⎠. (8)
Expression 8 gives the prior probability that no cut
points are present between any consecutive pairs of
values of X in the sequence Sai,bi and at least one cut
point is present between the values Xbi and Xbi+1. Using
the above notation and assumptions, and substituting
Equations 7 and 8 into Equation 4, we obtain the spe-
cialized EBD score:
Score(M)=
I  
i=1
⎡
⎣Prior(bi)
⎛
⎝
bi−1  
k=ai
(1 − Prior(k))
⎞
⎠ (J − 1)!
(J − 1+ni)!
J  
j=1
nij!
⎤
⎦. (9)
The above score assumes that the n values of X in the
dataset D are all distinct. However, the implementation
described below easily relaxes that assumption.
Dynamic Programming Search
The EBD method finds the discretization that maximizes
the score given in Equation 9 using dynamic program-
ming to search the space of possible discretizations. The
pseudocode for the EBD search method is given in
Figure 1. It is globally optimal in that it is guaranteed to
find the discretization with the highest score. Additional
details about the search method used by EBD and its
time complexity are provided in the Methods section.
The number of possible discretizations for a predictor
variable X in a dataset with n instances is 2
n-1,a n dt h i s
number is typically too large for each discretization to
be evaluated in a brute force manner. The EBD method
addresses this problem by the use of dynamic program-
ming that at every stage uses previously computed opti-
mal solutions to subproblems. The use of dynamic
programming reduces considerably the number of possi-
ble discretizations that have to be evaluated explicitly
without sacrificing the ability to identify the optimal
discretization.
An example of the application of the EBD method on
the example dataset D = ((1.2, 0), (1.4, 0), (1.6, 0), (3.7,
1), (3.9, 1), (4.1, 1)) is given in Figure 2. Although there
are 2
5 = 32 possible discretizations for a dataset of six
instances, as in this example, EBD explicitly evaluates
o n l y6o ft h e mi nd e t e r m i n i n gt h eh i g h e s ts c o r i n g
discretization.
As described in the Methods section, the EBD algo-
rithm runs in O(n
2)t i m e ,w h e r en is the number of
instances of a predictor X. Although EBD is slower than
FI, it is still feasible to apply EBD to high-dimensional
data with a large number of variables.
Evaluation of the Efficient Bayesian Discretization
(EBD) Method
We evaluated the EBD method and compared its perfor-
mance to the FI method on 24 biomedical datasets (see
Table 1) using five measures: accuracy, area under the
Receiver Operating Characteristic curve (AUC), robust-
ness, stability, and the mean number of intervals per
variable (a measure of model complexity). The last three
measures evaluate the discretized predictors directly
while the first two measures evaluate the performance
of classifiers that are learned from the discretized pre-
dictors. We performed this comparison using the FI
method, because it is so commonly used (1) in practice
and (2) as a standard algorithmic benchmark for discre-
tization methods.
For computing the evaluation measures we performed
10 × 10 cross-validation (10-fold cross-validation done
ten times to generate a total of 100 training and test
folds). For a pair of training and test folds, we learned a
discretization model for each variable (using either FI or
EBD) for the training fold only and applied the intervals
from the model to both the training and test folds to gen-
erate the discretized variables. For the experiments, we
set l, which is user specified parameter introduced in
Figure 1 and in Equation 10 (see the Methods section) to
be 0.5. The parameter l is the expected number of cut
points in the discretization of the variables in the domain.
Our previous experience with discretizing some of the
datasets used in the experiments with FI indicated that
the majority of the variables in these datasets have 1 or 2
intervals (that correspond to 0 or 1 cut points). We chose
l to be 0.5 as the average of 0 and 1 cut points.
We used two classifiers in our experiments, namely,
C4.5 and naïve Bayes (NB). C4.5 is a popular tree classi-
fier that accepts both continuous and discrete predictors
and has the advantage that the classifier can be inter-
preted as a set of rules. The NB classifier is simple, effi-
cient, robust, and accepts both continuous and discrete
predictors. It assumes that the predictors are condition-
ally independent of each other given the target value.
Given an instance, it applies Bayes theorem to compute
the probability distribution over the target values. This
classifier is very effective when the independence
assumptions hold in the domain; however, even if these
assumptions are violated, the classification performance
is often excellent, even when compared to more sophis-
ticated classifiers [16].
Accuracy is a widely used measure of predictive per-
formance (see the Methods section). The mean accura-
cies for EBD and FI for C4.5 and NB are given in
Table 2. EBD has higher mean accuracy on 17 datasets
for each of C4.5 and NB, respectively. FI has higher
mean accuracy on 4 datasets and 3 datasets for C4.5
and NB, respectively. EBD and FI have the same mean
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respectively. Overall, EBD shows an increase in accu-
racy of 2.02% and 0.76% for C4.5 and NB, respectively.
This increased performance is statistically significant at
the 5% significance level on the Wilcoxon signed rank
test for both C4.5 and NB.
T h eA U Ci sam e a s u r eo ft h ed i s c r i m i n a t i v ep e r f o r -
mance of a classifier that accounts for datasets that have
a highly skewed distribution over the target variable (see
the Methods section). The mean AUCs for EBD and FI
for C4.5 and NB are given in Table 3. For C4.5, EBD
has higher mean AUC on 17 datasets, FI has higher
Algorithm EBD  
Input: Dataset D and parameter Ȝ. 
Output: An optimal Bayesian discretization of variable X relative to D. 
Definitions of terms: 
Let D be a dataset of n instances consisting of the list ((X1, Z1), (X2, Z2), ..., (Xk, Zk), ..., (Xn, Zn)) that is
sorted in ascending order of Xk, where Xk is a real value of the predictor variable and Zk is the 
associated integer value of the target variable. 
Let Sa, b be a list of the first elements in D, starting at the a
th pair in D and ending at the b
th pair. 
Let Tb be a set that represents a discretization of S1, b. 
Let target variable Z have J unique values, and let Zj denote the j
th unique value. Let U be a real array 
of J elements, and let Uj denote its j
th element. U will contain the distribution of values of the target 
variable for some Sa, b. 
Let n’ be the number of unique values of predictor variable X, and let Xk denote the k
th unique value. 
Let V be a real array of n’ elements, and let Vy denote its y
th element. 
For 1  k  n’, let Wk = (countk, 1, countk, 2..., countk, J) be an array such that for 1  j  J, the term 
countk, j is equal to the number of pairs in D in which the first element has value Xk and the second 
element (i.e., the target value) has value Zj. 
Let MarginalLikelihood(U) be the following marginal likelihood function, which follows from 
Equation 7 when array U is used to derive the ni and nij counts: 
1
1
(1 ) !
() : !
(1 ) !
J
j J
j
j
j
J
MarginalLikelihood U U
JU
1
1)!
J 1)! 1)! ( ( (
1 1
!
J J
!
J
j
j
J
1
j)! j
j j j  
Let Prior(k) be the prior function defined in Equation 10 in the text. 
Lines of Code: 
1. V0 := 1; 
2. T0 := {};  
3. for a := 1 to n’ 
4.  P := Prior(a); 
5.  Va := 0; 
6. U  := (0, 0, ..., 0); 
7. for  b := a downto 1 
8.   U := U + Wb; /* element-wise addition */ 
9.   ML := MarginalLikelihood(U);    
10.   Score_ba := P × ML;  
11.   if  Vb-1 × Score_ba > Va        
12.   then 
13.     Ta := Tb-1  {Sb, a}; 
14.     Va :=  Vb-1 × Score_ba; 
15.   P := P × (1 – Prior(b-1)); 
16. return Tn’ 
Figure 1 Pseudocode for the efficient Bayesian discretization (EBD) method. The EBD method uses dynamic programming and runs in O
(n
2) time as indicated by the two for loops (n is the number of instances in the dataset).
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ods have the same mean AUC on 2 datasets. For NB,
EBD has higher mean AUC than FI on 16 datasets,
lower mean AUC on 6 datasets, and the same mean
AUC on two datasets. Overall, EBD shows an improve-
ment in AUC of 1.07% and 1.12% for C4.5 and NB,
respectively, and both increases in AUC are statistically
s i g n i f i c a n ta tt h e5 %l e v e lo nt h eW i l c o x o ns i g n e d
rank test.
Robustness is the ratio of the accuracy on the test
dataset to that on the training dataset expressed as a
percentage (see the Methods section). The mean robust-
ness for EBD and FI for C4.5 and NB are given in
Table 4. For C4.5, EBD has higher mean robustness on
10 datasets, FI has higher mean robustness on 11 data-
sets, and both have equivalent mean robustness on
three datasets. For NB, EBD has better performance
than FI on 9 datasets, worse performance on 13 data-
sets, and similar performance on two datasets. Overall,
EBD shows a small decrease in mean robustness of
0.26% and 0.68% for C4.5 and NB, respectively, that are
not statistically significant at the 5% level on the Wil-
coxon signed rank test.
Stability quantifies how different training datasets
affect the variables being selected (see the Methods sec-
tion). The mean stabilities for EBD and FI are given in
Table 5. Overall, EBD has higher stability than FI, but
only at an overall average of 0.02, which nevertheless is
statistically significant at the 5% significance level on the
Wilcoxon signed rank test.
Input:   D = ((1.2, 0), (1.4, 0), (1.6, 0), (3.7, 1), (3.9, 1), (4.1, 1))
S = (1.2, 1.4, 1.6, 3.7, 3.9, 4.1) 
 
a = 1    
b = 1  T1 = T0   {S1, 1} =  {S1, 1}*  
 
a =   2           
b = 2   T2 = T1   {S2, 2} =  {S1, 1, S2, 2}  
b = 1  T2 = T0   {S1, 2}* 
 
a  =  3          
b = 3   T3 = T2   {S3, 3} =  {S1, 2, S3, 3}  
  b = 2   T3 = T1   {S2, 3} =  {S1, 1, S2, 3}  
b = 1   T3 = T0   {S1, 3} =  {S1, 3}* 
 
a  =  4          
b = 4   T4 = T3   {S4, 4} =  {S1, 3, S4, 4}  
b = 3   T4 = T2   {S3, 4} =  {S1, 2, S3, 4}  
b = 2   T4 = T1   {S2, 4} =  {S1, 1, S2, 4}  
b = 1   T4 = T0   {S1, 4} =  {S1, 4}* 
 
a  =  5          
b = 5   T5 = T4   {S5, 5} =  {S1, 4, S5, 5}  
b = 4   T5 = T3   {S4, 5} =  {S1, 3, S4, 5}  
b = 3   T5 = T2   {S3, 5} =  {S1, 2, S3, 5}  
b = 2   T5 = T1   {S2, 5} =  {S1, 1, S2, 5}  
b = 1   T5 = T0   {S1, 5}* =  {S1, 5}* 
 
a  =  6          
b = 6   T6 = T5   {S6, 6} =  {S1, 5, S6, 6}  
b = 5   T6 = T4   {S5, 6} =  {S1, 4, S5, 6}  
b = 4   T6 = T3   {S4, 6} =  {S1, 3, S4, 6}*  
b = 3   T6 = T2   {S3, 6} =  {S1, 2, S3, 6}  
b = 2   T6 = T1   {S2, 6} =  {S1, 1, S2, 6}  
b = 1  T6 = T0   {S1, 6} =  {S1, 6} 
 
 
Output: T6 = {S1, 3, S4, 6} = {(1.2, 1.4, 1.6), (3.7, 3.9, 4.1)} 
 
* = discretization with the highest EBD score in iteration a 
Figure 2 An example of the application of the efficient
Bayesian discretization (EBD) method. This example shows the
progression of the EBD method when applying the pseudocode
given in Figure 1 to the dataset of six instances that is introduced
in the main text. An asterisk denotes the discretization with the
highest EBD score in a given iteration, as indexed by a. There are 2
5
= 32 possible discretizations for a dataset of six instances; for this
dataset EBD explicitly evaluates only the 6 discretizations shown in
bold font.
Table 1 Description of datasets
Dataset Dataset name Type P/D #t #n #V M
1 Alon et al. T D 2 61 6,584 0.651
2 Armstrong et al. T D 3 72 12,582 0.387
3 Beer et al. T P 2 86 5,372 0.795
4 Bhattacharjee et al. T D 7 203 12,600 0.657
5 Bhattacharjee et al. T P 2 69 5,372 0.746
6 Golub et al. T D 2 72 7,129 0.653
7 Hedenfalk et al. T D 2 36 7,464 0.500
8 Iizuka et al. T P 2 60 7,129 0.661
9 Khan et al. T D 4 83 2,308 0.345
10 Nutt et al. T D 4 50 12,625 0.296
11 Pomeroy et al. T D 5 90 7,129 0.642
12 Pomeroy et al. T P 2 60 7,129 0.645
13 Ramaswamy et al. T D 29 280 16,063 0.100
14 Rosenwald et al. T P 2 240 7,399 0.574
15 Staunton et al. T D 9 60 7,129 0.145
16 Shipp et al. T D 2 77 7,129 0.747
17 Su et al. T D 13 174 12,533 0.150
18 Singh et al. T D 2 102 10,510 0.510
19 Veer et al. T P 2 78 24,481 0.562
20 Welsch et al. T D 2 39 7,039 0.878
21 Yeoh et al. T P 2 249 12,625 0.805
22 Petricoin et al. P D 2 322 11,003 0.784
23 Pusztai et al. P D 3 159 11,170 0.364
24 Ranganathan et al. P D 2 52 36,778 0.556
In the Type column, T denotes transcriptomic and P denotes proteomic. In the
P/D column, P denotes prognostic and D denotes diagnostic. #t is the number
of values of the target variable and #n is the number of instances in the
dataset. #V is the number of predictor variables. M is the proportion of the
data that has the majority target value.
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by EBD and FI. The first column gives for each dataset
the proportion of predictor variables that were discre-
tized into a single interval, that is, there were no cut
points. Such predictors are considered uninformative
and are not used for learning a classifier. The second
column gives for each dataset the mean number of
intervals among those predictors that were discretized
to more than one interval. The third column reports the
mean number of intervals over all predictors, including
intervals that contain no cut points. Overall, the applica-
tion of EBD resulted in more predictors with more than
one interval, relative to the application of FI, by an over-
all average of 9%. Also, the mean number of intervals
per predictor was greater for EBD than for FI, but this
difference was not statistically significant at the 5% level
on the Wilcoxon signed rank test. This implies that
while the average for the EBD complexity is slightly
greater (1.27 versus 1.16 intervals per predictor), overall,
EBD and FI are similar in terms of complexity of the
discretizations produced.
The results of the statistical comparison of the EBD
and FI discretization methods using the Wilcoxon
paired samples signed rank test are given in Table 7. As
shown in the table, the accuracy and AUC of C4.5 and
NB classifiers were statistically significantly better at the
5% level when the predictor variables were discretized
using EBD over FI. EBD was statistically significantly
more stable to the variability of the datasets than FI.
However, EBD was less robust, though not statistically
significantly so, than FI and produced slightly more
complex discretizations than FI.
Running Times
We conducted the experiments on an AMD X2 4400 +
2.2 GHz personal computer with 2GB of RAM that was
running Windows XP. For the 24 datasets included in
our study, on average to discretize all the predictor
Table 2 Accuracies for the EBD and FI discretization
methods
Classifier C4.5 NB
Dataset EBD (SEM) FI (SEM) EBD (SEM) FI (SEM)
1 100.00%
(0.00)
100.00%
(0.00)
93.33% (0.93) 93.33% (0.85)
2 86.43% (0.79) 84.62% (0.77) 93.03% (1.06) 92.12% (0.94)
3 78.61% (1.30) 64.23% (1.72) 81.53% (1.11) 81.53% (1.02)
4 88.62% (0.66) 84.38% (0.67) 75.43% (0.83) 72.76% (0.79)
5 59.04% (1.72) 56.33% (1.93) 71.19% (0.92) 69.78% (1.13)
6 96.67% (1.10) 95.67% (0.82) 82.32% (1.17) 80.28% (1.51)
7 94.46% (1.03) 94.46% (1.03) 97.32% (0.84) 97.32% (0.84)
8 60.00% (2.08) 50.00% (2.03) 72.33% (1.42) 70.82% (1.49)
9 83.61% (1.28) 81.29% (0.97) 91.94% (0.91) 93.67% (0.72)
10 68.00% (1.98) 66.54% (1.21) 76.00% (1.65) 71.76% (1.32)
11 77.67% (1.30) 72.44% (0.91) 75.53% (1.33) 73.81% (1.11)
12 55.83% (2.14) 59.58% (2.12) 63.33% (1.81) 61.67% (1.84)
13 58.92% (0.86) 57.14% (0.96) 50.36% (0.84) 49.32% (0.88)
14 58.75% (0.91) 62.33% (1.01) 58.33% (1.04) 57.65% (1.09)
15 54.94% (0.72) 54.20% (0.74) 55.34% (1.70) 53.86% (1.07)
16 72.43% (1.32) 71.25% (1.45) 86.22% (1.41) 85.45% (1.22)
17 70.06% (0.94) 68.96% (1.17) 82.81% (0.79) 81.78% (1.42)
18 81.21% (0.58) 83.78% (0.68) 83.76% (0.91) 89.76% (0.75)
19 74.12% (1.32) 72.22% (1.21) 85.12% (1.09) 84.19% (1.31)
20 59.45% (2.08) 59.45% (2.08) 100.00%
(0.00)
100.00%
(0.00)
21 62.32% (1.54) 65.24% (1.43) 78.23% (0.59) 76.23% (0.54)
22 73.22% (0.78) 69.78% (1.21) 78.23% (0.77) 77.23% (0.78)
23 73.32% (0.92) 68.49% (0.98) 46.22% (0.98) 48.55% (0.87)
24 76.12% (1.32) 73.04% (1.72) 83.32% (1.65) 80.12% (1.23)
Average 73.49% (2.07) 71.48% (2.12) 77.55% (2.65) 76.79% (2.32)
Accuracies for EBD and FI discretization methods are obtained from the
application of C4.5 and NB classifiers to the discretized variables. The mean
and the standard error of the mean (SEM) for the accuracy for each dataset is
obtained by 10 × 10 cross-validation. For each dataset, the higher accuracy is
shown in bold font and equal accuracies are underlined.
Table 3 AUCs for the EBD and FI discretization methods
Classifier C4.5 NB
Dataset EBD FI EBD FI
1 98.00% (0.06) 98.00% (0.06) 69.32% (0.88) 66.79% (0.92)
2 73.19% (1.08) 69.37% (1.22) 78.58% (1.87) 79.96% (1.98)
3 57.24% (1.88) 55.42% (1.65) 56.08% (1.70) 54.16% (1.92)
4 68.37% (1.27) 69.43% (0.95) 58.12% (1.08) 59.72% (1.17)
5 55.21% (1.12) 54.38% (1.44) 56.87% (1.41) 53.91% (1.09)
6 61.54% (0.63) 60.11% (0.95) 88.21% (0.66) 86.38% (0.86)
7 88.45% (1.42) 88.45% (1.42) 91.35% (0.76) 91.35% (0.76)
8 54.11% (1.12) 55.49% (0.89) 58.76% (0.85) 59.61% (0.76)
9 88.34% (1.32) 86.90% (1.41) 87.65% (1.18) 84.28% (1.12)
10 76.45% (0.68) 74.30% (0.81) 85.44% (0.99) 82.59% (1.04)
11 68.25% (0.71) 66.12% (0.61) 72.38% (1.01) 70.74% (0.98)
12 56.65% (1.21) 55.14% (1.06) 57.89% (0.95) 53.72% (0.86)
13 70.45% (0.87) 73.18% (0.65) 69.89% (0.71) 71.55% (0.75)
14 56.32% (1.12) 55.16% (0.98) 54.42% (0.98) 55.12% (0.96)
15 76.12% (0.87) 73.49% (1.01) 89.45% (0.89) 91.27% (0.56)
16 82.21% (1.31) 80.06% (1.12) 82.86% (1.17) 80.11% (1.09)
17 78.65% (1.41) 80.15% (1.32) 78.14% (1.12) 75.98% (1.24)
18 94.75% (0.87) 92.31% (0.90) 96.12% (0.65) 94.19% (0.72)
19 76.31% (1.25) 74.23% (1.14) 82.42% (1.03) 81.16% (1.24)
20 94.12% (1.19) 95.43% (1.21) 100.00% (0.00) 100.00% (0.00)
21 54.24% (0.75) 52.13% (0.46) 55.09% (0.43) 54.92% (0.65)
22 64.18% (0.94) 60.65% (0.98) 64.87% (0.89) 64.25% (0.71)
23 83.24% (0.76) 81.56% (0.79) 77.23% (0.97) 76.17% (0.88)
24 80.86% (1.01) 80.21% (0.89) 84.72% (0.89) 81.21% (0.77)
Average 73.22% (1.89) 72.15% (1.77) 74.83% (1.43) 73.71% (1.24)
AUCs for EBD and FI discretization methods are obtained from the application
of C4.5 and NB classifiers to the discretized variables. The mean and the
standard error of the mean (SEM) for the AUC for each dataset is obtained by
10 × 10 cross-validation. For each dataset, the higher AUC is shown in bold
font and equal AUCs are underlined.
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Page 8 of 15variables in a dataset, EBD took 20 seconds per training
fold while FI took 5 seconds per training fold.
Discussion
We have developed an efficient Bayesian discretization
method that uses a Bayesian score to evaluate a discreti-
zation and employs dynamic programming to efficiently
search and identify the optimal discretization. We evalu-
ated the performance of EBD on several measures and
compared it to the performance of FI. Table 8 shows
the number of wins, draws and losses when comparing
EBD to FI on accuracy, AUC, stability and robustness.
On both accuracy and AUC, which are measures of dis-
crimination performance, EBD demonstrated statistically
significant improvement over FI. EBD was more stable
than FI, which indicates that EBD is less sensitive to the
variability of the training datasets. FI was moderately
better in terms of robustness, but not statistically
significantly so. On average, EBD produced slightly
more intervals per predictor variable, as well as a greater
proportion of predictors that had more than one inter-
val. Thus, EBD produced slightly more complex discreti-
zations than FI.
A distinctive feature of EBD is that it allows the speci-
fication of parameter and structure priors. Although we
used non-informative parameter priors in the evaluation
reported here, EBD readily supports the use of informa-
tive prior probabilities, which enables users to specify
background knowledge that can influence how a predic-
tor variable is discretized. The alpha parameters in
Equation 6 are the parameter priors. Suppose there are
two similar biomedical datasets A and B containing the
same variables, but different populations of individuals,
and we are interested in discretizing the variables. The
data in A could provide information for defining the
parameter priors in Equation 6 before its application to
the data in B. There is a significant amount of flexibility
in defining this mapping for using data in a similar (but
not identical) biomedical dataset to influence the discre-
tization of another dataset. The lambda parameter in
Table 4 Robustness for the EBD and FI discretization
methods
Classifier C4.5 NB
Dataset EBD (SEM) FI (SEM) EBD (SEM) FI (SEM)
1 100.00%
(0.00)
100.00%
(0.00)
94.94% (0.89) 94.94% (0.97)
2 90.64% (0.77) 87.69% (0.86) 94.36% (0.98) 95.17% (1.05)
3 70.78% (2.00) 53.57% (2.10) 82.44% (1.10) 81.69% (1.14)
4 84.18% (0.76) 85.87% (0.77) 90.10% (1.09) 75.91% (1.09)
5 49.83% (2.01) 53.08% (2.18) 69.97% (1.20) 86.88% (1.12)
6 83.58% (1.34) 80.58% (1.42) 97.76% (1.12) 95.89% (0.92)
7 92.50% (1.18) 92.50% (1.18) 96.67% (0.86) 97.27% (0.86)
8 55.50% (2.16) 55.11% (2.06) 70.94% (1.48) 71.67% (1.43)
9 90.61% (0.95) 87.16% (0.99) 98.98% (0.74) 96.08% (0.94)
10 75.10% (1.48) 68.65% (1.39) 74.35% (2.05) 76.93% (1.81)
11 70.36% (0.95) 70.47% (0.93) 78.25% (1.22) 82.52% (1.20)
12 57.82% (2.22) 61.04% (2.21) 63.47% (1.87) 65.94% (1.88)
13 66.12% (0.39) 66.96% (0.37) 64.89% (1.05) 50.83% (1.02)
14 57.47% (0.94) 64.13% (1.06) 67.01% (1.08) 69.18% (1.08)
15 54.94% (0.72) 54.20% (0.74) 54.16% (1.75) 61.60% (1.70)
16 73.17% (1.66) 77.17% (1.79) 92.57% (1.39) 84.11% (1.38)
17 82.71% (1.35) 87.43% (1.21) 88.25% (1.56) 85.49% (1.60)
18 79.38% (0.57) 82.65% (0.57) 88.91% (0.72) 91.81% (0.83)
19 73.00% (1.48) 79.00% (1.30) 85.55% (1.31) 85.89% (1.29)
20 58.75% (2.09) 58.75% (2.08) 100.00%
(0.00)
100.00%
(0.00)
21 55.18% (1.26) 62.23% (1.13) 77.01% (0.60) 76.10% (0.57)
22 72.53% (0.96) 66.84% (1.03) 90.87% (0.89) 81.15% (0.93)
23 78.16% (1.04) 76.07% (0.99) 77.79% (1.67) 52.49% (1.73)
24 75.00% (1.78) 70.00% (1.75) 80.33% (1.64) 99.86% (1.70)
Average 72.55% (2.81) 72.81% (2.76) 81.72% (2.92) 82.40% (2.59)
The mean and the standard error of the mean (SEM) for robustness for each
dataset is obtained by 10 × 10 cross-validation. For each dataset, the higher
robustness value is shown in bold font and equal robustness values are
underlined.
Table 5 Stabilities for the EBD and FI discretization
methods
Dataset EBD FI
1 0.83 0.80
2 0.84 0.84
3 0.68 0.67
4 0.82 0.84
5 0.54 0.50
6 0.79 0.80
7 0.81 0.79
8 0.58 0.55
9 0.84 0.82
10 0.83 0.81
11 0.80 0.75
12 0.50 0.50
13 0.76 0.78
14 0.53 0.53
15 0.65 0.59
16 0.80 0.79
17 0.81 0.75
18 0.76 0.82
19 0.75 0.69
20 0.88 0.84
21 0.60 0.42
22 0.86 0.85
23 0.89 0.94
24 0.59 0.61
Average 0.74 0.72
The mean stability for each dataset is obtained by 10 × 10 cross-validation.
For each dataset, the higher stability value is shown in bold font and equal
stability values are underlined.
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Page 9 of 15Table 6 Mean number of intervals per predictor variable for the EBD and FI discretization methods
Mean fraction of predictors with 1 interval Mean # of intervals per predictor with >1 interval Mean # of intervals per predictor
Dataset EBD FI EBD FI EBD FI
1 0.81 0.84 2.02 2.01 1.15 1.16
2 0.47 0.61 2.06 2.04 1.48 1.41
3 0.91 0.96 2.02 2.01 1.05 1.04
4 0.18 0.28 2.20 2.16 1.91 1.84
5 0.97 0.99 2.03 2.04 1.01 1.01
6 0.87 0.89 2.01 2.01 1.13 1.11
7 0.82 0.86 2.02 2.01 1.13 1.14
8 0.97 0.98 2.02 2.02 1.01 1.02
9 0.54 0.76 2.11 2.12 1.42 1.27
10 0.38 0.65 2.06 2.06 1.53 1.37
11 0.51 0.77 2.06 2.10 1.41 1.25
12 0.98 0.99 2.02 2.02 1.01 1.01
13 0.05 0.90 2.57 2.10 2.39 1.11
14 0.98 0.99 2.03 2.02 1.01 1.01
15 0.70 0.98 2.08 2.12 1.20 1.02
16 0.75 0.87 2.01 2.01 1.12 1.13
17 0.76 0.85 2.04 2.04 1.16 1.16
18 0.17 0.78 2.31 2.13 1.99 1.25
19 0.87 0.94 2.05 2.02 1.06 1.06
20 0.81 0.85 2.02 2.10 1.15 1.17
21 0.97 0.99 2.01 2.02 1.01 1.01
22 0.82 0.84 2.14 2.14 1.16 1.18
23 0.93 0.97 2.01 2.02 1.05 1.03
24 0.92 0.95 2.06 2.02 1.04 1.05
Average 0.76 0.85 2.08 2.06 1.27 1.16
The mean fraction of predictor variables discretized to one interval (no cut points), the mean number of intervals for predictor variables discretized to more than
one interval (at least one cut point), and the mean number of intervals for all predictor variables for each dataset is obtained by 10-fold cross-validation done
ten times. For each dataset, the higher value is shown in bold font and equal values are underlined.
Table 7 Statistical comparison of EBD and FI discretization methods
Evaluation Measure Method Mean (SEM) Difference of Means Z statistic (p-value)
C4.5 Accuracy EBD 73.49% (2.07) 2.01 2.219
[0%, 100%] FI 71.48% (2.12) (0.026)
C4.5 AUC EBD 73.22% (1.89) 1.07 2.732
[50%, 100%] FI 72.15% (1.77) (0.007)
C4.5 Robustness EBD 72.55% (2.81) -0.26 -0.261
[0%, ∞] FI 72.81% (2.76) (0.794)
NB Accuracy EBD 77.55% (2.65) 0.76 2.080
[0%, 100%] FI 76.79% (2.32) (0.038)
NB AUC EBD 74.83% (1.43) 1.11 2.711
[0%, 100%] FI 73.71% (1.24) (0.007)
NB Robustness EBD 81.72% (2.92) -0.68 -0.016
[50%, ∞] FI 82.40% (2.59) (0.987)
Stability EBD 0.74 (0.025) 0.02 1.972
[0, 1] FI 0.72 (0.029) (0.049)
Mean # of intervals per predictor EBD 1.27 (0.074) 0.11 1.686
[1, n] FI 1.16 (0.038) (0.092)
In the first column the range of a measure is given in square brackets where n is the number of instances in the dataset. In the last column the number on top
in the last column is the Z statistic and the number at the bottom is the corresponding p-value. On all performance measures, except for the mean number of
intervals per predictor, the Z statistic is positive when EBD performs better than FI. The two-tailed p-values of 0.05 or smaller are in bold, indicating that EBD
performed statistically significantly better at that level.
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the user to provide a structure prior. This is where prior
knowledge might be particularly helpful by specifying
(probabilistically) the expected number of cut points per
predictor variable. Although we have presented a struc-
ture prior that is based on a Poisson distribution, the
EBD algorithm can be readily adapted to use other dis-
tributions. In doing so, the main assumption is that a
structure prior of an interval can be composed as a pro-
duct of the structure priors of its subintervals.
The running times show that although EBD runs
slower than FI, it is sufficiently fast to be applicable to
real-world, high-dimensional datasets. Overall, our
results indicate that EBD is easy to implement and is
sufficiently fast to be practical. Thus, we believe EBD is
an effective discretization method that can be useful
when applied to high-dimensional biomedical data.
We note that EBD and FI differ in both in the score
used for evaluating candidate discretizations and in the
search method employed. As a result, the differences in
performance of the two methods may be due to the
score, the search method, or a combination of the two.
A version of FI could be developed that uses dynamic
programming to minimize its cost function, namely
entropy, in a manner directly parallel to the EBD algo-
rithm that we introduce in this paper. Such a compari-
son, however, is beyond the scope of the current paper.
Moreover, since the FI method was developed and is
implemented widely using greedy search, we compared
E B Dt oi tr a t h e rt h a nt oam o d i f i e dv e r s i o no fF Iu s i n g
dynamic programming search. It would be interesting in
future research to evaluate the performance of a
dynamic programming version of FI.
Conclusions
High-dimensional biomedical data obtained from tran-
scriptomic and proteomic studies are often pre-pro-
cessed for analysis that may include the discretization of
continuous variables. Although discretization of continu-
ous variables may result in loss of information, discreti-
zation offers several advantages. It broadens the range of
data mining methods that can be applied, can reduce
the time taken for the data mining methods to run, and
can improve the predictive performance of some data
mining methods. In addition, the thresholds and inter-
vals produced by discretization have the potential to
assist the investigator in selecting biologically meaning-
ful intervals. For example, the intervals selected by dis-
cretization for a transcriptomic variable provide a
starting point for defining normal, over-, and under-
expression for the corresponding gene.
The FI discretization method is a popular discretiza-
tion method that is used in a wide range of domains.
While it is computationally efficient, it is not guaranteed
to find the optimal discretization for a predictor vari-
able. We have developed a Bayesian discretization
method called EBD that is guaranteed to find the opti-
mal discretization (i.e., the discretization with the high-
est Bayesian score) and is also sufficiently
computationally efficient to be applicable to high-
dimensional biomedical data.
Methods
Biomedical Datasets
The performance of EBD was evaluated on a total of 24
datasets that included 21 publicly available transcrip-
tomic datasets and two publicly available proteomic
datasets that were acquired on the Surface Enhanced
Laser/Desorption Ionization Time of Flight (SELDI-
TOF) mass spectrometry platform. Also included was a
University of Pittsburgh proteomic dataset that contains
diagnostic data on patients with Amyotrophic Lateral
Sclerosis; this data were acquired on the SELDI-TOF
platform [17]. The 24 datasets along with their types,
number of instances, number of variables, and the
majority target value proportions are given in Table 1.
The 23 publicly available datasets used in our experi-
ments have been extensively studied in prior investiga-
tions [17-34].
Additional Details about the EBD Algorithm
In this section, we first provide additional details about
the Prior probability function that is used by EBD. Next,
we discuss details of the EBD pseudocode that appears
in Figure 1.
Let D be a dataset of n instances consisting of the list
((X1, Z1), (X2, Z2), ..., (Xk, Zk), ..., (Xn, Zn)) that is sorted
in ascending order of Xk,w h e r eXk is a real value of the
predictor variable and Zk is the associated integer value
of the target variable. Let l be the mean of a Poisson
distribution that represents the expected number of cut
points between X1 and Xn in discretizing X to predict Z.
N o t et h a tz e r o ,o n e ,o rm o r et h a no n ec u tp o i n t sc a n
occur between any two consecutive values of X in the
training set. Let Prior(k) be the prior probability of there
Table 8 Summary of wins, draws and losses of EBD
versus FI
Evaluation Measure Wins Draws Losses
C4.5 Accuracy 17 3 4
C4.5 AUC 17 2 5
C4.5 Robustness 10 3 11
NB Accuracy 17 4 3
NB AUC 16 2 6
NB Robustness 9 2 13
Stability 15 3 6
Number of wins, draws and losses on accuracy, AUC, robustness and stability
for EBD and FI.
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Page 11 of 15being at least one cut point between values Xk and Xk +
1 in the training set. For k from 1 to n-1, we define the
EBD Prior function as follows:
Prior(k)=1− e
−λ
d(k,k +1 )
d(1,n) ,
(10)
where, d(a, b)=Xb - Xa represents the distance
between the two values Xa and Xb of X,a n dXb is
greater than Xa. When k = 0 and k = n, boundary condi-
tions occur. We need an interval below the lowest value
of X in the training set and above the highest value.
Thus, we define Prior(0) = 1, which corresponds to the
lowest interval, and Prior(n) = 1, which corresponds to
the highest interval.
The EBD pseudocode shown in Figure 1 works as fol-
lows. Consider finding the optimal discretization of the
subsequence S1, a for a being some value between 1 and
n.
3 Assume we have already found the highest scoring
discretization of X for each of the subsequences S1,1,
S1,2, ..., S1,a-1.L e tV1, V2,. . . ,Va-1 denote the respective
scores of these optimal discretizations. Let Scorei be the
score of subsequence Si, a when it is considered as a sin-
gle interval, that is, it has no internal cut points; this
term is denoted as the variable Score_ba in Figure 1. For
all b from a to 1, EBD computes Vb -1× Score_ba,
which is the score for the highest scoring discretization
of S1, a that includes Sb, a as a single interval. Since this
score is derived from two other scores, we call it a com-
posite score. The fact that this composite score is a pro-
duct of two scores follows from the decomposition of
t h es c o r i n gm e a s u r ew ea r eu s i n g ,a sg i v e nb yE q u a t i o n
9. In particular, both the prior and the marginal likeli-
hood components of that score are decomposable. Over
all b, EBD chooses the maximum composite score,
which corresponds to the optimal discretization of S1, a;
this score is stored in Va. By repeating this process for a
from 1 to n, EBD derives the optimal discretization of
S1, n, which is our overall goal.
Several lines of the pseudocode in Figure 1 deserve
comments. Line 8 incrementally builds a frequency
(count) distribution for the target variable, as the subse-
quence Sb, a is extended. Line 11 determines if a better
discretization has been found for the subsequence S1, a.
If so, the new (higher) score and its corresponding dis-
cretization are stored in Va and Ta, respectively. Line 15
incrementally updates P to maintain a prior that is con-
sistent with there being no cut points in the subse-
quence Sba .
We can obtain the time complexity of EBD as follows.
The statements in lines 1 and 2 clearly require O(1) run
time. The outer loop, which starts at line 3, executes n
times. In that loop lines 3-5 require O(1) time per
execution, and line 6 requires O(J) time per execution,
where J i st h en u m b e ro fv a l u e so ft h et a r g e tv a r i a b l e .
Thus, the statements in the outer loop require a total of
O(J·n) time. The inner loop, which starts at line 7, loops
O(n
2) times. In it lines 8 and 9 require O(J)t i m e ,a n d
the remaining lines require O(1) time. Thus, the state-
ments in the inner loop require a total of O(J·n
2)o fr u n
time.
4 Therefore, the overall time complexity of EBD is
O(J·n
2). Assuming there is an upper bound on the value
of J, then the complexity of EBD is simply O(n
2).
The numbers computed within EBD can become very
small. Thus, it is most practical to use logarithmic arith-
metic. A logarithmic version of EBD, called lnEBD, is
given in Additional file 1.
Discretization and Classification
For the FI discretization method, we used the imple-
mentation in the Waikato Environment for Knowledge
Acquisition (WEKA) version 3.5.6 [35]. We implemen-
ted the EBD discretization method in Java so that it can
be used in conjunction with WEKA. For our experi-
ments, we used the J4.8 classifier (which is WEKA’s
implementation of C4.5) and the naïve Bayes classifier
as implemented in WEKA. Given an instance for which
the target value is to be predicted, both classifiers com-
pute the probability distribution over the target values.
In our evaluation, the distribution over the target values
was used directly; if a single target value was required,
the target variable was assigned the value that had the
highest probability.
Evaluation Measures
We conducted experiments for the EBD and FI discreti-
zation methods using 10 × 10 cross-validation. The dis-
cretization methods were evaluated on the following five
measures: accuracy, area under the Receiver Operating
Characteristic curve (AUC), robustness, stability, and
the average number of intervals per variable.
Accuracy is a widely used performance measure for
evaluating a classifier and is defined as the proportion of
correct predictions of the target made by the classifier
relative to the number of test instances (samples). The
AUC is another commonly used discriminative measure
for evaluating classifiers. For a binary classifier, the AUC
can be interpreted as the probability that the classifier
will assign a higher score to a randomly chosen instance
that has a positive target value than it will to a randomly
chosen instance with a negative target value. For data-
sets in which the target takes more than two values, we
used the method described by Hand and Till [36] for
computing the AUC.
Robustness is defined as the ratio of the accuracy on
the test dataset to that on the training dataset expressed
as a percentage [5]. It assesses the degree of overfitting
of a discretization method.
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method to differences in training datasets, and it quanti-
fies how different training datasets affect the variables
being selected. Discretization can be viewed as a variable
selection method, in that variables with a non-trivial
discretization are selected while variables with a trivial
discretization are discarded when the discretized vari-
ables are used in learning a classifier. A variable has a
trivial discretization if it is discretized to a single interval
(i.e., has no cut points) while it has a non-trivial discre-
tization if it is discretized to more than one interval (i.e.,
has at least one cut-point).
We used a stability measure that is an extension of the
measure developed by Kuncheva [37]. To compute sta-
bility, first a similarity measure is defined for two sets of
variables that, for example, would be obtained from the
application of a discretization method to two training
datasets on the same variables. Given two sets of
selected variables, vi and vj, the similarity score we used
is given by the following equation:
Sim(vi,vj)=
r −
kikj
n
min(ki,kj) −
kikj
n
, (11)
where, ki is the number of variables in vi, kj is the
number of variables in vj, r is the number of variables
that are present in both vi and vj, n is the total number
of variables, min(ki, kj)i st h es m a l l e ro fki or kj and
represents the largest value r can attain, and
kikj
n
is the
expected value of r that is obtained by modeling r as a
random variable with a hypergeometric distribution.
This similarity measure computes the degree of com-
monality between two sets with an arbitrary number of
variables, and it varies between -1 and 1 with 0 indicat-
ing that the number of variables common to the two
sets can be obtained simply by random selection of ki or
kj variables from n variables, and 1 indicating that the
two sets are contain the same variables. When vi or vj
or both have no variables, or both vi and vj contain all
predictor variables, Sim(vi, vj) is undefined, and we
assume the value of the similarity measure to be 0.
Experimental Methods
In performing cross validation, each training set (fold)
contains a set of variables that are assigned one or more
cutpoints; we can consider these as the selected predic-
tor variables for that fold. We would like to measure
how similar are the selected variables among all the
training folds. For a single run of 10-fold cross valida-
tion, the similarity scores of all possible pairs of folds
are calculated using Equation 11. With 10-fold cross
validation, there are 45 pairs of folds, and stability is
computed as the average similarity over all these pairs.
For the ten runs of 10-fold cross-validation, we averaged
the stability scores obtained from the ten runs to obtain
an overall stability score. The stability score varies
between -1 and 1; a better discretization method will be
more stable and hence have a higher score.
For comparing the performance of the discretization
methods, we used the Wilcoxon paired samples signed
rank test. This is a non-parametric procedure concern-
ing a set of paired values from two samples that tests
the hypothesis that the population medians of the sam-
ples are the same [38]. In evaluating discretization
methods, it is used to test whether two such methods
differ significantly in performance on a specified evalua-
tion measure.
Endnotes
1 This is based on a search with the phrase “Fayyad
and Irani’s discretization” that we performed on Decem-
ber 24, 2010.
2 However, in general we can use background knowl-
edge and belief to set the values of the aij.
3 Technically, we should use the term n’ here, as it is
defined in Figure 1, but we use n for simplicity of
notation.
4 We note that line 13 requires some care in its
implementation to achieve O(1) time complexity, but it
can be done by using an appropriate data structure.
Also, the MarginalLikelihood function requires comput-
ing factorials from 1! to as high as (J-1 + n)!; these fac-
torials can be precomputed in O(n) time and stored for
use in the MarginalLikelihood function.
Additional material
Additional file 1: Logarithmic Version of EBD. Contains pseudocode
for a logarithmic version of EBD.
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